8B7-26735-10825
1 vaccination
1 coded response
2 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 208 / MD
- Registered
- 2022-07-17
- Relationship
- Child or adolescent in my care
- Guardian
- W2D-46851-67657
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-23
Dose 1 — Moderna
-
2022-07-17
Registered in v-safe
-
2022-07-17
Survey response — day 21, dose 1, dependentMedDRA: Cough, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolFree text: Cough, runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-12-24
Health check-in — 6 months, dose 1, dependentFeeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Influenza AAdult check-in · check-in free text available
- 2022-12-24
- 2022-12-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-23 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-12-24 | Unsuccessful |
Free text
Release 12 — day 21, dose 1, dependent
Symptoms: Cough, runny nose
Release 12 — 6 months, dose 1, dependent
Symptoms: Influenza A
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release